WHO WE ARE
Diabetes CRO Partner & Expert in Human Cell Reprogramming
HUMAN CELL DESIGN
Truly Translational Human Cell Models
Human Cell Design provides Contract Research Organization (CRO) services from target validation to pre-clinical in vitro profiling services. With over 12 years of expertise in evaluating drug targeting diabetes, Human Cell Design has developed (1) in-house gold standard fully reprogrammed human functional cell lines and in parallel (2) robust CRO-associated services. We offer customized solutions tailored to perfectly fit our partner’s priorities in terms of delay, throughput, and design. As a committed CRO, we are dedicated to helping you achieve accelerated development and commercialization outcomes while ensuring the highest levels of efficiency and cost-effectiveness.
OUR VISION
Getting Better Medication to Patients Faster
Here at Human Cell Design, we are convinced that human cell models are the way forward to getting better medication to patients faster. Beyond replicating human reality through physiologically relevant models, we also provide stable and large quantity of human cells.
We are dedicated to providing innovative models that deliver reproducible and robust data over the years, ensuring consistent and reliable long-term data analysis along with strategic insights. We empower our customers to use a single, relevant model from target validation to preclinical studies, guaranteeing continuity and data capitalization while saving valuable time and resources.
This approach is the key to success for our customers, and our daily priority at Human Cell Design.
Company History
A UNIQUE COMBINATION OF HUMAN CELL EXPERTISE
2001
ENDOCELLS
Endocells experts pioneer the development of a late-stage maturation platform that amplify and terminally differentiate progenitor cells towards functional adult-like cells
2013
THE NATLINE® PLATFORM
EndoC-βH1® is created using the Natline® cell maturation platform
2020
ENDOC-βH5®
Human Cell Design team succeeds in reprogramming a human beta cell with a fully similar function to the one of native pancreatic islets
2010
UNIVERCELL BIOSOLUTIONS
UniverCell Biosolutions pioneers in differentiating mature functional cardiomyocytes from reprogrammed human induced pluripotent stem cells (hiPSc)
2015
HUMAN CELL DESIGN
UniverCell Biosolutions and EndoCells combine their complementary expertise to create Human Cell Design
2022
CRO FOCUSED ON DIABETES
Human Cell Design launches a full range of CRO activities leveraging its pioneering expertise on human beta cells and Type 1 & 2 diabetes assay development
2001
ENDOCELLS
Endocells experts pioneer the development of a late-stage maturation platform that amplify and terminally differentiate progenitor cells towards functional adult-like cells
2010
UNIVERCELL BIOSOLUTIONS
UniverCell Biosolutions pioneers in differentiating mature functional cardiomyocytes from reprogrammed human induced pluripotent stem cells (hiPSc)
2013
THE NATLINE® PLATFORM
EndoC-βH1® is created using the Natline® cell maturation platform
2015
HUMAN CELL DESIGN
UniverCell Biosolutions and EndoCells combine their complementary expertise to create Human Cell Design
2020
ENDOC-βH5®
Human Cell Design team succeeds in reprogramming a human beta cell with a fully similar function to the one of native pancreatic islets
2022
CRO FOCUSED ON DIABETES
Human Cell Design launches a full range of CRO activities leveraging its pioneering expertise on human beta cells and Type 1 & 2 diabetes assay development
